Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4711 AL 4725

Astrocytes in physiological aging and Alzheimer's disease

Rodríguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A.

Neuroscience. 2016 May 26;323:170-82. doi: 10.1016/j.neuroscience.2015.01.007. Epub 2015 Jan 14.

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Louis Tisserand G, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”; Hippocampus Study Group.

Alzheimers Dement. 2015 Sep;11(9):1041-9. doi: 10.1016/j.jalz.2014.10.003. Epub 2015 Jan 14.

A systems approach to drug discovery in Alzheimer's disease

Shelanski M, Shin W, Aubry S, Sims P, Alvarez MJ, Califano A.

Neurotherapeutics. 2015 Jan;12(1):126-31. doi: 10.1007/s13311-014-0335-5.

The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans

May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ.

J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015.

Screening strategies to identify HSP70 modulators to treat Alzheimer's disease

Repalli J, Meruelo D.

Drug Des Devel Ther. 2015 Jan 7;9:321-31. doi: 10.2147/DDDT.S72165. eCollection 2015.

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy

Campbell NL, Skaar TC, Perkins AJ, Gao S, Li L, Khan BA, Boustani MA.

Clin Interv Aging. 2015 Jan 14;10:269-75. doi: 10.2147/CIA.S65980. eCollection 2015.

MicroRNA landscape in Alzheimer's disease

Cogoni C, Ruberti F, Barbato C.

CNS Neurol Disord Drug Targets. 2015;14(2):168-75. doi: 10.2174/1871527314666150116123305.

Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study

Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, Cederholm T, Palmblad J, Schultzberg M.

J Lipid Res. 2015 Mar;56(3):674-681. doi: 10.1194/jlr.P055418. Epub 2015 Jan 23.

Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?

Ferreira ME, de Vasconcelos AS, da Costa Vilhena T, da Silva TL, da Silva Barbosa A, Gomes AR, Dolabela MF, Percário S.

Cell Mol Neurobiol. 2015 Jul;35(5):595-614. doi: 10.1007/s10571-015-0157-y. Epub 2015 Jan 24.

Statins and cognitive function: an updated review

Chatterjee S, Krishnamoorthy P, Ranjan P, Roy A, Chakraborty A, Sabharwal MS, Ro R, Agarwal V, Sardar P, Danik J, Giri JS, DeGoma EM, Kumbhani DJ.

Curr Cardiol Rep. 2015 Feb;17(2):4. doi: 10.1007/s11886-014-0559-3.

Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection

Kaur U, Banerjee P, Bir A, Sinha M, Biswas A, Chakrabarti S.

Curr Top Med Chem. 2015;15(5):446-57. doi: 10.2174/1568026615666150114160543.

The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer's Disease

Gomes B, Loureiro JA, Coelho MA, Pereira Mdo C.

Curr Pharm Des. 2015;21(39):5725-35. doi: 10.2174/1381612821666150130120358.

Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect

Miguel-Álvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, Lucia A.

Drugs Aging. 2015 Feb;32(2):139-47. doi: 10.1007/s40266-015-0239-z.

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease

Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M.

J Alzheimers Dis. 2015;45(3):679-88. doi: 10.3233/JAD-142850.

The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease

Wright JW, Harding JW.

J Alzheimers Dis. 2015;45(4):985-1000. doi: 10.3233/JAD-142814.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias